Transferrin Receptor-Targeted Nanocomplexed Anti-R2 siRNA CALAA-01
Cancer Terms ->
Drugs and Chemicals ->
Pharmacologic Substance ->
Antineoplastic Agent -> Transferrin Receptor-Targeted Nanocomplexed Anti-R2 siRNA CALAA-01
Transferrin Receptor-Targeted Nanocomplexed Anti-R2 siRNA CALAA-01 Definition
A proprietary transferrin receptor-targeted nanoparticle preparation of a non-chemically modified small-interfering RNA (siRNA) directed against the M2 subunit of ribonucleotide reductase (RRM2) with potential antineoplastic activity. Upon administration, transferrin receptor-targeted anti-RRM2 siRNA CALAA-01 binds to transferrin receptors (TfRs), releasing anti-RRM2 siRNA after endocytosis; anti-RRM2 siRNA silences the expression of RRM2 via the RNAi pathway, impeding the assembly of the holoenzyme ribonucleotide reductase (RR) which catalyzes the production of deoxyribonucleotides. As a result, inhibition of cellular proliferation may occur in cells expressing TfR, a cell surface protein overexpressed on various cancer cell types.
Transferrin Receptor-Targeted Nanocomplexed Anti-R2 siRNA CALAA-01 Synonyms
Transferrin Receptor-Targeted Anti-RRM2 siRNA CALAA-01, CALAA-01
Terms in Transferrin Receptor-Targeted Nanocomplexed Anti-R2 siRNA CALAA-01 category
Copyright © Cancer Terms 2014 All rights reserved. | Terms of Use | Low Carb Foods
No reproduction or republication permitted.